Although existing CRISPR-Cas-based imaging methods can target endogenous genomic sequences, their applications are limited by ...
Higher yields, greater resilience to climatic changes or diseases—the demands on crop plants are constantly growing. To ...
The Global Gene Editing Market, valued at USD 4.68 billion in 2023, is poised for transformative growth, projected to expand at a compound annual growth rate (CAGR) of 10.2% through 2033. This dynamic ...
The immune system plays a crucial role in fighting tumors and metastases. Consequently, it is decisive to conduct cancer ...
M OST STORIES about gene-edited children begin with He Jiankui, a rogue Chinese scientist who, in 2018, announced that he had ...
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...
CorriXR Therapeutics, Inc., an oncology-focused biotherapeutics company pioneering a novel gene editing platform to overcome drug resistance in solid tumors, today announced the publication of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback